Polaryx Therapeutics, Inc.
Polaryx Therapeutics is a clinical-stage biotechnology company developing small molecule and gene therapies for rare lysosomal storage disorders.
8-KSep 14Latest SEC filing, period to Sep 10
Sep 1Latest story
Polaryx Therapeutics is a clinical-stage biotechnology company developing small molecule and gene therapies for rare lysosomal storage disorders.